SPACInsider Logo
Genius Sports (GENI) Commences Warrant Consent Solicitation
by Marlena Haddad on 2022-11-18 at 10:54am

Genius Sports (NYSE:GENI), which completed its combination with dMY Technology Group Inc. II in April 2021, announced this morning that it has started a solicitation of consents from holders of outstanding warrants to amend the exercise period so the warrants will expire on January 18, 2023, instead of on April 20, 2026.

If GENI is able to receive more than 50% approval from the warrant holders, then the holders will have the opportunity to exercise on a cashless basis and receive 0.26 common shares for each exercised warrant.

Additionally, Genius Sports issued warrant holders a notice indicating that the company has lowered the exercise price of the warrants from $11.50 to a price that is 74% of the closing price of the ordinary shares on the NYSE on the trading day prior to the date of delivery of an exercise notice. Yesterday’s close price was $4.49, which equates to $3.3226.

If the warrant amendment is approved, the warrants will stop trading on the NYSE on January 18, 2023 and all previously unexercised warrants will expire worthless on such date.

As of November 17, a total of 7,668,381 warrants were outstanding. The consent solicitation is expected to expire on its expiration date of December 16.

The company’s stock is currently down -2.48% in early morning trading following today’s announcement. GENI warrants (NASDAQ:GENIWS), however, are up about +50% to $1.20. Genius Sports hopes to simplify its capital structure and reduce the potential dilutive impact of the warrants through this solicitation, thereby providing the company with more financial flexibility.

dMY Technology Group, Inc. II originally announced its $1.5 billion combination with Genius Sports in October 2020 and completed the deal in April 2021. London-based Genius Sports supplies sports betting operators with official data and streaming media services and is partnered with about 500 sports organizations including the NBA, Premier League and NCAA.

Recent Posts
by Nicholas Alan Clayton on 2023-01-30 at 12:07am

Prime Impact I (NYSE:PIAI) has entered into a definitive agreement to combine with auto insurance firm Cheche at an enterprise value of $841 million, or about 2.3x its 2022 revenue. Beijing-based Cheche provides a digital insurance platform for car owners in China with about 34 million vehicles covered. The combined company is expected to trade...

by Marlena Haddad on 2023-01-30 at 11:42am

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News: Hambro Perks eyes merger with Biotech Istesso, Rocket Lab launches first vehicle from U.S. soil, and Alliance Entertainment signs licensing agreement with The Walt Disney Company Hambro Perks SPAC Eyes Merger With Biotech...

by Marlena Haddad on 2023-01-30 at 10:15am

Pono Capital Corp. (NASDAQ:PONO) disclosed in an 8-K filing this morning that its shareholders approved its combination with air mobility company AERWINS at a special meeting held on Friday, January 27. Holders of 12,412,861 common shares were present at the meeting and the deal was approved with 11,218,712 shares in favor of the transaction. The filing did not...

by Nicholas Alan Clayton on 2023-01-30 at 9:07am

European Biotech (NASDAQ:EBAC) announced in an 8-K this morning that it has increased its PIPE by $7.8 million and added $7 million to the convertible loans attached to the combination with biotech firm Oculis. The new PIPE cash comes at $10 per share and joins $63.3 million in existing PIPE financing for a total of...

by Nicholas Alan Clayton on 2023-01-30 at 7:17am

DHC Acquisition Corp (NASDAQ:DHCA) announced that it is formally terminating its combination with conservative banking venture GloriFi. This was essentially a formality because the SPAC already announced in November that GloriFi had begun the process of winding down.  The two sides announced their $1.7 billion combination in July. But, even at the time, public details...

Privacy Policy|Terms Of Use
Copyright © 2022 SPACInsider, Inc. All Rights Reserved